Course Accreditation

Recent Industry Update

• Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis
• Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
• PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease
• AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum
• Pfizer submitted application for emergency use of Covid vaccine
• Take Self Competency Test in Esxport Documentation
• Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
• US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease
• Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning
• Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda
• MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine
• Understanding on India’s Revised Patent Rules On Priority filing w.e.f 19 October, 2020
• Insight of BioInvent’s licensing deal of anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals
• Case Study – Inmazeb: USFDA Approval of first ebola medicine
• Pfizer’s Hospital Business acquires Arixa Pharma
• Insight on Veklury’s clinical and strategic pathway for USFDA approval for Covid-19
• Case Study: Rinvoq’s brand Dermatology market expansion strategy
• Sobrera, Recipharm Collaborate to Advance Alcohol Use Disorder Treatment
• Centaur Pharma launches WOXheal to treat diabetic foot ulcers
• FSD Pharma gets US FDA nod to begin phase 2 study of FSD201 to treat COVID-19
• AbbVie’s Elezanumab receives US FDA orphan drug and fast track designations
• USFDA granted expanded access to investigational ERK inhibitor ulixertinib
• Case Study – Strategic Insight on Gilead and Immunomedics $21 Billion Deal
• Insight on USFDA approval of pralsetinib to treat non-small lung cancer
• What is hybrid clinical trial?
• Strides Pharma to acquire 54% stake in SteriScience
• Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine
• Insight on First approved COVID-19 vaccine Sputnik V
• Novavax and Serum Institute of India – licensing agreement for Development and Commercial Collaboration
• Novavax reports positive results from phase 1 trial of COVID-19 vaccine candidate, NVX-CoV2373 with Matrix-M